POTENTIAL THERAPEUTIC ADVANTAGE FOR DUVELISIB IN MANTLE CELL LYMPHOMA: PI3Kδ AND OVEREXPRESSED PI3Kγ IN LYMPHOMA CELLS HAVE SPECIALIZED FUNCTIONAL ROLES

Hematological Oncology - United Kingdom
doi 10.1002/hon.194_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

ISY9-2New Therapeutic Strategies for Mantle Cell Lymphoma

Annals of Oncology
MedicineOncologyHematology
2018English

Targeting WNT Pathway in Mantle Cell Lymphoma-Initiating Cells

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas

Advances in Hematology
Hematology
2012English

Incidence and Survival Trends in Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2017English

New Molecular Targets in Mantle Cell Lymphoma

Seminars in Cancer Biology
Cancer Research
2011English

New Treatment Options in Mantle Cell Lymphoma

European Oncology and Haematology
OncologyHematology
2015English

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

Splenectomy in the Treatment of Mantle Cell Lymphoma

Hematology & blood transfusion: interdepartamental collection
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy